{
  "ticker": "VRTX",
  "year": 2026,
  "quarter": 1,
  "last_updated": "2026-02-02T08:51:48.470174",
  "count": 11,
  "transactions": [
    {
      "id": 431,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP,  Chief Scientific Officer",
      "transaction_date": "2026-01-22",
      "transaction_shares": "7866",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "31149"
    },
    {
      "id": 432,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2026-01-22",
      "transaction_shares": "7866",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "50159"
    },
    {
      "id": 433,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2026-01-22",
      "transaction_shares": "9012",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "33039"
    },
    {
      "id": 434,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2026-01-22",
      "transaction_shares": "7866",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "67115"
    },
    {
      "id": 435,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "McKechnie Duncan",
      "reporting_owner_cik": "0002062139",
      "reporting_owner_position": "EVP, Chief Commercial Officer",
      "transaction_date": "2026-01-22",
      "transaction_shares": "4720",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "20858"
    },
    {
      "id": 436,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2026-01-22",
      "transaction_shares": "26972",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "142940"
    },
    {
      "id": 437,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2026-01-22",
      "transaction_shares": "3934",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "20786"
    },
    {
      "id": 438,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP, CO & FO",
      "transaction_date": "2026-01-22",
      "transaction_shares": "9440",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "47165"
    },
    {
      "id": 439,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2026-01-22",
      "transaction_shares": "2950",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10795"
    },
    {
      "id": 440,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2026-01-22",
      "transaction_shares": "6294",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "21600"
    },
    {
      "id": 441,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2026-01-22",
      "transaction_shares": "7866",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "40535"
    }
  ]
}